{"mainPropery":{"diseaseId":1608,"diseaseName":"X-linked creatine deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/1608/x-linked-creatine-deficiency","synonyms":["Mental retardation , X-linked with seizures, short stature and midface hypoplasia","Mental retardation , X-linked, with creatine transport deficiency","X-linked creatine transporter deficiency","X-linked creatine deficiency syndrome","Creatine deficiency, X-linked"],"synonyms-with-source":[{"name":"Mental retardation , X-linked with seizures, short stature and midface hypoplasia"},{"name":"Mental retardation , X-linked, with creatine transport deficiency"},{"name":"X-linked creatine transporter deficiency"},{"name":"X-linked creatine deficiency syndrome"},{"name":"Creatine deficiency, X-linked"}],"identifiers":[{"identifierType":"OMIM","identifierId":"300352"},{"identifierType":"ORPHANET","identifierId":"52503"},{"identifierType":"UMLS","identifierId":"C1845862"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":37,"diseaseTypeName":"Newborn Screening"}],"organizations":[{"resourceID":3145,"resourceName":"Association for Creatine Deficiencies","abbreviation":"","address1":"6965 El Camino Real","address2":"Suite 105-598","address3":"","address4":"","address5":"","city":"Carlsbad","state":"CA","zip":"92009","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"kim@creatineinfo.org","url":"http://creatineinfo.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/300352' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=X-linked%5Btiab%5D%20AND%20creatine%20deficiency%5Btitle%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss X-linked creatine deficiency. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/x-linked-creatine-deficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on X-linked creatine deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1321,"resourceId":1982,"resourceName":"National Newborn Screening and Global Resource Center","descriptionText":"<a href='https://www.newbornscreening.info/iva-isovaleric-acidemia/' target='_blank'>National Newborn Screening and Global Resource Center</a> (NNSGRC) provides information and resources in the area of newborn screening and genetics to benefit health professionals, the public health community, consumers and government officials.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1845862' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=52503' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK3794/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/MONDO:0010305' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":9640,"questionText":"What is X-linked creatine deficiency?","answerText":"<strong>X-linked creatine deficiency</strong>&nbsp;primarily affects development of the brain and nervous system. Symptoms can begin at any age, but usually begin in early childhood. These symptoms can include mild to severe intellectual disability, delayed speech development, behavioral problems, and <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003200.htm\" tabindex=\"-1\" target=\"_blank\">seizures</a>. The intellectual disability may get worse over time. X-linked creatine deficiency is caused by a <em><a href=\"http://ghr.nlm.nih.gov/gene/SLC6A8\" tabindex=\"-1\" target=\"_blank\">SLC6A8</a></em> gene that is not working correctly. It is inherited in an <a href=\"http://www.genome.gov/Glossary/index.cfm?id=209\" tabindex=\"-1\" target=\"_blank\">X-linked</a>&nbsp;pattern. Diagnosis is based on screening tests, clinical exam, and genetic testing. Treatment is focused on managing the symptoms.[9944][15719][15720][15721]&nbsp;&nbsp;","dateModified":"2020-08-04T00:00:00"},"basicQuestions":[{"questionId":13572,"questionText":"What are the signs and symptoms of X-linked creatine deficiency?","answerText":"The following list includes the most common signs and symptoms in people with X-linked creatine deficiency. These features may be different from person to person. Some people may have more symptoms than others and symptoms can range from mild to severe. This list does not include every symptom or feature that has been described in this condition.<br />\r\n<br />\r\nSigns and symptoms may include:[9944][15719][15720]<br />\r\n<ul>\r\n    <li><a href=\"https://www.cdc.gov/ncbddd/developmentaldisabilities/facts-about-intellectual-disability.html\" target=\"_blank\">Intellectual disability</a></li>\r\n    <li>Delayed speech and language development</li>\r\n    <li>Behavioral issues</li>\r\n    <li><a href=\"https://medlineplus.gov/seizures.html\" target=\"_blank\">Seizures</a></li>\r\n    <li>Low muscle tone (<a href=\"https://medlineplus.gov/ency/article/003298.htm\" target=\"_blank\">hypotonia</a>)</li>\r\n    <li>Uncoordinated movement (<a href=\"https://medlineplus.gov/ency/article/003198.htm\" target=\"_blank\" style=\"font-size: 12pt;\">ataxia</a><span style=\"font-size: 12pt;\">)</span></li>\r\n    <li><span style=\"font-size: 12pt;\">Gastrointestinal symptoms</span></li>\r\n</ul>\r\nSymptoms usually begin in childhood, but sometimes occur much later. Some of the symptoms of X-linked creatine deficiency may get worse over time, especially intellectual disability.[9944][15719]","dateModified":"2020-08-05T10:53:00","resourceClassificationName":"Symptoms","references":[{"referenceId":9944,"authors":"Mercimek-Mahmutoglu S, Salomons GS","articleTitle":"Creatine Deficiency Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Dec. 10, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK3794","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15719,"authors":"van de Kamp JM, Btsalel OT, Mercimek-Mahmutoglu S, et al","articleTitle":"Phenotype and genotype in 101 males with X-linked creatine transporter deficiency","bookWebsiteJournalTitle":"J Med Genet","date":"2013","volume":"50(7)","pages":"463-472","url":"https://pubmed.ncbi.nlm.nih.gov/23644449","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15720,"authors":"Miller JS, Thomas RP, Bennett A, et al","articleTitle":"Early Indicators of Creatine Transporter Deficiency","bookWebsiteJournalTitle":"J Pediatr","date":"2019","volume":"206","pages":"283-285","url":"https://pubmed.ncbi.nlm.nih.gov/30579583","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13575,"questionText":"How is X-linked creatine deficiency inherited?","answerText":"X-linked creatine deficiency is inherited in an X-linked pattern.[9944][15719] X-linked means that the gene for the condition is located on the X-chromosome, one of the sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene is enough to cause the condition. In females (who have two X chromosomes), an alteration needs to occur in both copies of the gene to cause the condition.&nbsp; <br />\r\n<br />\r\nX-linked recessive conditions affect males much more often than females. Females, who have one altered gene, are called carriers. While, most female carriers have no signs or symptoms of the condition, in rare cases, female carriers may experience some mild signs or symptoms.<br />\r\n<br />\r\nA female who carries one X-linked gene alteration has a 50% or 1 in 2 chance of having a son with the condition and a 50% chance of having a daughter who is also a carrier. A male with an X-linked recessive condition cannot pass on the disorder to his sons, but all of his daughters will be carriers.<br />\r\n<br />\r\nSometimes a male child is the first person in a family with the condition. In this case, the gene alteration may have been inherited from the mother, or the alteration may have occurred by chance for the first time in the child (de novo).<br />\r\n<br />","dateModified":"2020-08-05T12:01:00","resourceClassificationName":"Inheritance","references":[{"referenceId":15719,"authors":"van de Kamp JM, Btsalel OT, Mercimek-Mahmutoglu S, et al","articleTitle":"Phenotype and genotype in 101 males with X-linked creatine transporter deficiency","bookWebsiteJournalTitle":"J Med Genet","date":"2013","volume":"50(7)","pages":"463-472","url":"https://pubmed.ncbi.nlm.nih.gov/23644449","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13574,"questionText":"How is X-linked creatine deficiency diagnosed?","answerText":"X-linked creatine deficiency is diagnosed based on the symptoms, clinical exam, and the results of genetic testing.[9944][15722] Screening tests looking for levels of specific chemicals in the urine are often used prior to genetic testing.","dateModified":"2020-08-05T11:42:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":9944,"authors":"Mercimek-Mahmutoglu S, Salomons GS","articleTitle":"Creatine Deficiency Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Dec. 10, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK3794","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15722,"authors":"Sharer JD, Bdamer O, Longo N, Tortorelli S, Wamelink MM, Young S","articleTitle":"Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics","bookWebsiteJournalTitle":"Genet Med","date":"2017","volume":"19(2)","pages":"256-263","url":"https://pubmed.ncbi.nlm.nih.gov/28055022","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13576,"questionText":"How might X-linked creatine deficiency be treated?","answerText":"Treatment for X-linked creatine deficiency is focused on managing the symptoms.[15720]&nbsp;<br />\r\n<br />\r\nSpecialists involved in the care of someone with X-linked creatine may include:<br />\r\n<ul>\r\n    <li>Neurologist</li>\r\n    <li>Speech/language pathologist</li>\r\n    <li>Occupational therapy</li>\r\n    <li>Physical therapy</li>\r\n</ul>","dateModified":"2020-08-05T12:08:00","resourceClassificationName":"Treatment","references":[{"referenceId":15720,"authors":"Miller JS, Thomas RP, Bennett A, et al","articleTitle":"Early Indicators of Creatine Transporter Deficiency","bookWebsiteJournalTitle":"J Pediatr","date":"2019","volume":"206","pages":"283-285","url":"https://pubmed.ncbi.nlm.nih.gov/30579583","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13573,"questionText":"What is the cause of X-linked creatine deficiency?","answerText":"X-linked creatine deficiency occurs when the&nbsp;<em><a href=\"https://ghr.nlm.nih.gov/gene/SLC6A8\" target=\"_blank\">SLC6A8</a>&nbsp;</em>gene is not working correctly. DNA changes known as pathogenic <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/variant\" target=\"_blank\">variants</a> are responsible for making genes work incorrectly or sometimes, not at all.[9944]&nbsp;","dateModified":"2020-08-05T11:25:00","resourceClassificationName":"Cause","references":[{"referenceId":9944,"authors":"Mercimek-Mahmutoglu S, Salomons GS","articleTitle":"Creatine Deficiency Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Dec. 10, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK3794","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13577,"questionText":"How many people have X-linked creatine deficiency?","answerText":"It is unclear how many people have X-linked creatine deficiency. It has been reported in over 150 patients.[15722] It may account for about 2% of males with intellectual disability.&nbsp;","dateModified":"2020-08-05T12:19:00","resourceClassificationName":"Statistics","references":[{"referenceId":15722,"authors":"Sharer JD, Bdamer O, Longo N, Tortorelli S, Wamelink MM, Young S","articleTitle":"Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics","bookWebsiteJournalTitle":"Genet Med","date":"2017","volume":"19(2)","pages":"256-263","url":"https://pubmed.ncbi.nlm.nih.gov/28055022","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":15719,"authors":"van de Kamp JM, Btsalel OT, Mercimek-Mahmutoglu S, et al","articleTitle":"Phenotype and genotype in 101 males with X-linked creatine transporter deficiency","bookWebsiteJournalTitle":"J Med Genet","date":"2013","volume":"50(7)","pages":"463-472","url":"https://pubmed.ncbi.nlm.nih.gov/23644449","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15720,"authors":"Miller JS, Thomas RP, Bennett A, et al","articleTitle":"Early Indicators of Creatine Transporter Deficiency","bookWebsiteJournalTitle":"J Pediatr","date":"2019","volume":"206","pages":"283-285","url":"https://pubmed.ncbi.nlm.nih.gov/30579583","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15721,"authors":"van de Kamp JM, Mancini GM, Salomons GS","articleTitle":"X-linked creatine transporter deficiency: clinical aspects and pathophysiology","bookWebsiteJournalTitle":"J Inherit Metab Dis. 2014;37(5):715-733","date":"2014","volume":"37(5)","pages":"715-733","url":"https://pubmed.ncbi.nlm.nih.gov/24789340","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15722,"authors":"Sharer JD, Bdamer O, Longo N, Tortorelli S, Wamelink MM, Young S","articleTitle":"Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics","bookWebsiteJournalTitle":"Genet Med","date":"2017","volume":"19(2)","pages":"256-263","url":"https://pubmed.ncbi.nlm.nih.gov/28055022","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9944,"authors":"Mercimek-Mahmutoglu S, Salomons GS","articleTitle":"Creatine Deficiency Syndromes","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Dec. 10, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK3794","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":2720,"phenoTypeName":"Abnormal circulating creatine concentration","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14142,"phenoTypeName":"Delayed speech and language development","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11214,"phenoTypeName":"Aganglionic megacolon","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11405,"phenoTypeName":"Athetosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6021,"phenoTypeName":"Autistic behavior","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3609,"phenoTypeName":"Cachexia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13706,"phenoTypeName":"Chorea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13409,"phenoTypeName":"Constipation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9421,"phenoTypeName":"Dystonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14144,"phenoTypeName":"Hyperactivity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8734,"phenoTypeName":"Hypertonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13771,"phenoTypeName":"Ileus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14219,"phenoTypeName":"Malar flattening","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9794,"phenoTypeName":"Open mouth","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14135,"phenoTypeName":"Self-mutilation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15092,"phenoTypeName":"Joint hyperflexibility","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9896,"phenoTypeName":"Mask-like facies","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9844,"phenoTypeName":"Microcephaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5615,"phenoTypeName":"Ptosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4740,"phenoTypeName":"Redundant skin","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13037,"phenoTypeName":"Abnormality of metabolism/homeostasis","percentRanges":"-"},{"phenoTypeId":6013,"phenoTypeName":"Aggressive behavior","percentRanges":"-"},{"phenoTypeId":4486,"phenoTypeName":"Attention deficit hyperactivity disorder","percentRanges":"-"},{"phenoTypeId":10412,"phenoTypeName":"Broad forehead","percentRanges":"-"},{"phenoTypeId":15398,"phenoTypeName":"Delayed myelination","percentRanges":"-"},{"phenoTypeId":9167,"phenoTypeName":"Exotropia","percentRanges":"-"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","percentRanges":"-"},{"phenoTypeId":3410,"phenoTypeName":"Feeding difficulties in infancy","percentRanges":"-"},{"phenoTypeId":9379,"phenoTypeName":"Gait disturbance","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":5647,"phenoTypeName":"Hypermetropia","percentRanges":"-"},{"phenoTypeId":13712,"phenoTypeName":"Hypoplasia of the corpus callosum","percentRanges":"-"},{"phenoTypeId":14129,"phenoTypeName":"Impaired social interactions","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":5679,"phenoTypeName":"Joint hypermobility","percentRanges":"-"},{"phenoTypeId":9870,"phenoTypeName":"Long face","percentRanges":"-"},{"phenoTypeId":10381,"phenoTypeName":"Mandibular prognathia","percentRanges":"-"},{"phenoTypeId":12272,"phenoTypeName":"Midface retrusion","percentRanges":"-"},{"phenoTypeId":8729,"phenoTypeName":"Motor delay","percentRanges":"-"},{"phenoTypeId":13446,"phenoTypeName":"Myopathic facies","percentRanges":"-"},{"phenoTypeId":14220,"phenoTypeName":"Narrow face","percentRanges":"-"},{"phenoTypeId":9405,"phenoTypeName":"Neonatal hypotonia","percentRanges":"-"},{"phenoTypeId":3896,"phenoTypeName":"Pes cavus","percentRanges":"-"},{"phenoTypeId":10705,"phenoTypeName":"Poor hand-eye coordination","percentRanges":"-"},{"phenoTypeId":7495,"phenoTypeName":"Reduced brain creatine level by MRS","percentRanges":"-"},{"phenoTypeId":8711,"phenoTypeName":"Spasticity","percentRanges":"-"},{"phenoTypeId":6026,"phenoTypeName":"Stereotypy","percentRanges":"-"},{"phenoTypeId":10035,"phenoTypeName":"Tall stature","percentRanges":"-"},{"phenoTypeId":6158,"phenoTypeName":"Underfolded superior helices","percentRanges":"-"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","percentRanges":"-"},{"phenoTypeId":5707,"phenoTypeName":"X-linked recessive inheritance","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"X-linked_creatine_deficiency"}